NextCell Pharma AB (OSTO:NXTCL) Interest Expense : kr-0.00 Mil (TTM As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. NextCell Pharma AB's interest expense for the three months ended in Feb. 2024 was kr -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Feb. 2024 was kr-0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. NextCell Pharma AB's Operating Income for the three months ended in Feb. 2024 was kr -10.40 Mil. NextCell Pharma AB's Interest Expense for the three months ended in Feb. 2024 was kr -0.00 Mil. NextCell Pharma AB did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NextCell Pharma AB Interest Expense Historical Data

The historical data trend for NextCell Pharma AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Interest Expense Chart

NextCell Pharma AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Interest Expense

Get a 7-Day Free Trial

-0.01

NextCell Pharma AB Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

NextCell Pharma AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.00 Mil.

NextCell Pharma AB (OSTO:NXTCL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NextCell Pharma AB's Interest Expense for the three months ended in Feb. 2024 was kr-0.00 Mil. Its Operating Income for the three months ended in Feb. 2024 was kr-10.40 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Feb. 2024 was kr0.00 Mil.

NextCell Pharma AB's Interest Coverage for the quarter that ended in Feb. 2024 is calculated as

NextCell Pharma AB did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

NextCell Pharma AB (OSTO:NXTCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

65G:Germany

Address

Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157

Website

http://www.nextcellpharma.com

NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines